Cotazym ECS

Pays: Nouvelle-Zélande

Langue: anglais

Source: Medsafe (Medicines Safety Authority)

Ingrédients actifs:

Amylase 30000 USP U (Component of pancrelipase); Pancrelipase 275mg; Protease 30000 USP U (Component of pancrelipase); Rizolipase 8000 USP U (Component of pancrelipase)

Disponible depuis:

Schering-Plough a division of Schering-Plough Animal Health Limited

DCI (Dénomination commune internationale):

Amylase 30000 USP U (Component of pancrelipase)

Dosage:

8k/30k/30kUSP U

forme pharmaceutique:

Capsule

Composition:

Active: Amylase 30000 USP U (Component of pancrelipase) Pancrelipase 275mg Protease 30000 USP U (Component of pancrelipase) Rizolipase 8000 USP U (Component of pancrelipase) Excipient: Cellacefate Colloidal silicon dioxide Diethyl phthalate Gelatin Hydrated silica Maize starch Opacode Povidone Propylene glycol Propylene glycol monostearate Purified talc Sodium laurilsulfate Sucrose

Unités en paquet:

Bottle, plastic, 250 capsules

classe:

General sale

Type d'ordonnance:

General sale

Fabriqué par:

Pancap Inc

Descriptif du produit:

Package - Contents - Shelf Life: Bottle, plastic, - 250 capsules - 24 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze). For Warehouse and Pharmacy 90 days opened stored at or below 25°C. For patient use

Date de l'autorisation:

1987-02-03